<DOC>
	<DOCNO>NCT00328393</DOCNO>
	<brief_summary>The anti-diabetic pioglitazone find reduce casual blood pressure . To date , data available look effect detail . Especially , ambulatory blood pressure yet utilized confirm hypothesis pioglitazone blood pressure lower effect .</brief_summary>
	<brief_title>Effect Pioglitazone Ambulatory Blood Pressure</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Pioglitazone</mesh_term>
	<criteria>Age 4575 year Diabetes mellitus Type 2 ( HbA1c 7 8.5 % ) Casual blood pressure &gt; = 130/80 mmHg , &lt; 160/100 mmHg Therapy insulin Combination therapy sulfonylurea und metformin Therapy nateglinid , repaglinid substance drug family Allergy pioglitazone composite tablet History heart failure ( NYHA I bis IV ) Hepatic insufficiency Transaminases &gt; 2.5fold upper normal limit Endstage renal failure Syndrome polycystic ovary Absence effective contraception woman childbearing potential Pregnancy breastfeeding</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Hypertension</keyword>
</DOC>